AlphaCentric Advisors’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
6,948
+99
+1% +$2.91K 0.2% 150
2026
Q1
$212K Buy
6,849
+373
+6% +$9.18K 0.21% 139
2025
Q4
$135K Buy
+6,476
New +$120K 0.13% 185
2021
Q1
Sell
-1,475
Closed -$247K 221
2020
Q4
$247K Buy
+1,475
New +$262K 0.1% 55

Other funds holding TECX

AlphaCentric Advisors's TECX Position: Q2 2026 in Review

AlphaCentric Advisors increased its Tectonic Therapeutic (TECX) stake by 1.4% in Q2 2026, buying an estimated $2.91K and bringing the position to 6,948 shares worth $239K. The position accounts for 0.2% of the portfolio, ranked #150.

AlphaCentric Advisors first reported a position in TECX in Q4 2020 and has held it in 4 quarters since. The position peaked at $247K in Q4 2020. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • AlphaCentric Advisors held 6,948 shares of Tectonic Therapeutic worth $239K as of Q2 2026.
  • AlphaCentric Advisors bought 99 Tectonic Therapeutic shares in Q2 2026, an estimated $2.91K.
  • Tectonic Therapeutic made up 0.2% of AlphaCentric Advisors's portfolio in Q2 2026, its #150 holding.
  • AlphaCentric Advisors first reported a position in Tectonic Therapeutic in Q4 2020 and has held it in 4 quarters since.
  • AlphaCentric Advisors's Tectonic Therapeutic position peaked at $247K in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.